| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |